Concepedia

Christine Boussiquet-Leroux

CB

4

Publications

137

Citations

4

H-Index

1992

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

MSD (France)

Christine Boussiquet-Leroux is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in urology, physiology, and medicine.

Top concepts

Publications per year

1992–2006

4

Publications

4

The Novel γ Secretase Inhibitor N-[cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) Reduces Amyloid Plaque Deposition without Evidence of Notch-Related Pathology in the Tg2576 Mouse

Jonathan D. Best, David W. Smith, Michael Reilly et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 83 citations

Evaluation of lymphocyte proliferation by immunohistochemistry in the local lymph node assay

Christine Boussiquet-Leroux, G. Durand‐Cavagna, K. Herlin et al. · Journal of Applied Toxicology · 1995 · 25 citations

Rat Urinary Bladder Hyperplasia Induced by Oral Administration of Carbonic Anhydrase Inhibitors

Sylvain Molon-Noblot, Christine Boussiquet-Leroux, E. Irisarri et al. · Toxicologic Pathology · 1992 · 19 citations

, , +12

Renal Papillary Cytoplasmic Granularity and Potassium Depletion Induced by Carbonic Anhydrase Inhibitors in Rats

G. Durand‐Cavagna, Sylvain Molon-Noblot, Christine Boussiquet-Leroux et al. · Toxicologic Pathology · 1993 · 10 citations

, , +14

Rows per page

1–4 of 4